Cargando…

Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer

BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wen, Ma, Junjun, Meng, Lifeng, Liu, Dabei, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044834/
https://www.ncbi.nlm.nih.gov/pubmed/35473511
http://dx.doi.org/10.1186/s12885-022-09593-2
_version_ 1784695189059665920
author Zhou, Wen
Ma, Junjun
Meng, Lifeng
Liu, Dabei
Chen, Jun
author_facet Zhou, Wen
Ma, Junjun
Meng, Lifeng
Liu, Dabei
Chen, Jun
author_sort Zhou, Wen
collection PubMed
description BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles homolog 3 (TRIB3) dependent manner. RESULT: Integrin αvβ3 could mediate the activation of FAK/AKT pro-survival signaling pathway. Meanwhile, activated TRIB3 interacted with AKT to upregulated FOXO1 and SOX2 expression, resulting in sustained tumor progression in lung cancer. Our further analysis revealed that TRIB3 was significantly upregulated in lung tumor tissues and correlated with the poor outcome in clinical patients, indicating the potential role of TRIB3 in diagnostic and prognostic estimation for patients with lung cancer. CONCLUSION: Our study showed here for the first time that integrin αvβ3 promote lung cancer development by activating the FAK/AKT/SOX2 axis in a TRIB3 dependent signaling pathway, and interrupting TRIB3/AKT interaction significantly improved the outcome of chemotherapy in tumor-bearing mice, representing a promising therapeutic strategy in lung cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09593-2.
format Online
Article
Text
id pubmed-9044834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90448342022-04-28 Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer Zhou, Wen Ma, Junjun Meng, Lifeng Liu, Dabei Chen, Jun BMC Cancer Research BACKGROUND: Integrin αvβ3 has been proposed as crucial determinant for tumor sustained progression and a molecular marker for the estimation of tumor angiogenesis. Our study suggested that integrin αvβ3 could efficiently promote lung cancer cell proliferation and stem-like phenotypes in a tribbles homolog 3 (TRIB3) dependent manner. RESULT: Integrin αvβ3 could mediate the activation of FAK/AKT pro-survival signaling pathway. Meanwhile, activated TRIB3 interacted with AKT to upregulated FOXO1 and SOX2 expression, resulting in sustained tumor progression in lung cancer. Our further analysis revealed that TRIB3 was significantly upregulated in lung tumor tissues and correlated with the poor outcome in clinical patients, indicating the potential role of TRIB3 in diagnostic and prognostic estimation for patients with lung cancer. CONCLUSION: Our study showed here for the first time that integrin αvβ3 promote lung cancer development by activating the FAK/AKT/SOX2 axis in a TRIB3 dependent signaling pathway, and interrupting TRIB3/AKT interaction significantly improved the outcome of chemotherapy in tumor-bearing mice, representing a promising therapeutic strategy in lung cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09593-2. BioMed Central 2022-04-26 /pmc/articles/PMC9044834/ /pubmed/35473511 http://dx.doi.org/10.1186/s12885-022-09593-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Wen
Ma, Junjun
Meng, Lifeng
Liu, Dabei
Chen, Jun
Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title_full Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title_fullStr Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title_full_unstemmed Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title_short Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
title_sort deletion of trib3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044834/
https://www.ncbi.nlm.nih.gov/pubmed/35473511
http://dx.doi.org/10.1186/s12885-022-09593-2
work_keys_str_mv AT zhouwen deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer
AT majunjun deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer
AT menglifeng deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer
AT liudabei deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer
AT chenjun deletionoftrib3disruptsthetumorprogressioninducedbyintegrinavb3inlungcancer